Mount Sinai’s Cancer Science in the Spotlight at 2025 ASCO
The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai is proud to announce its robust presence at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place this week in Chicago. With more than 15 presentations, including oral abstracts, poster sessions, and collaborative studies across multiple disciplines, Mount Sinai investigators are contributing vital insights that are shaping the future of cancer care.
“Our experts continue to lead the way in addressing some of the most urgent challenges in oncology, from novel therapeutics and immunotherapy to cancer care delivery and health equity,” said Ramon E. Parsons, MD, PhD, Director of The Tisch Cancer Institute and Dean for Cancer Research at the Icahn School of Medicine at Mount Sinai. “The volume and depth of our contributions to ASCO this year reflect our relentless commitment to improving cancer outcomes through research, innovation, and collaboration. Our investigators are not only advancing science—they are advancing hope for patients everywhere.”
Notable oral presentations and posters from Mount Sinai faculty at the 2025 ASCO Annual Meeting:
John Mascarenhas, MD
Rapid Oral Abstract Session
Abstract #6515
Sundar Jagannath, MD
Oral Abstract Session
Abstract # 7507
Fionnuala Crowley, MBBS
Abstract #TPS2696
Melanie Kier, MD
Abstract # TPS5623
Poster Bd #518b
Triparna Sen, PhD
Abstract #8091
Poster Bd #212
Evaluating palliative care needs of early-phase clinical trial patients.
Fionnuala Crowley, MBBS
Abstract #12086
Poster Bd #106
Shared decision-making in follow-up care for lung cancer screening.
Nihal Mohamed, PhD
Abstract #12114
Poster Bd #134
Antoine Jeri-Yabar, MD
Abstract #11038
Poster Bd #377
Global cervical cancer outcomes and national cancer system characteristics.
Erin Jay Feliciano, MD, MBA
Abstract #5535
Poster Bd #433
Yan Leyfman, MD
Abstract #10598
Poster Bd #323
Matthew Galsky, MD
Abstract #4580
Poster Bd #380
Susu Zhou, MD
Abstract #5088
Poster Bd #287
John Sfakianos, MD
Abstract #4597
Poster Bd #397
Thomas Marron, MD, PhD
Abstract #2577
Poster Bd #224
John Mascarenhas, MD
Abstract #TPS6588
Poster Bd #200a
Sundar Jagannath, MD
Abstract #7531
Poster Bd #99
Larysa Sanchez, MD
Abstract #TPS7565
Poster Bd #132a
For more information about the 2025 ASCO annual meeting visit https://www.asco.org/annual-meeting
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.